Ader R, Cohen N (1975) Behaviorally conditioned immunosuppression. Psychosom Med 37:333–340

Article  CAS  PubMed  Google Scholar 

Ader R, Cohen N (1993) Psychoneuroimmunology: conditioning and stress. Annu Rev Psychol 44:53–85

Article  CAS  PubMed  Google Scholar 

Albring A, Wendt L, Benson S, Nissen S, Yavuz Z, Engler H, Witzke O, Schedlowski M (2014) Preserving learned immunosuppressive placebo response: perspectives for clinical application. Clin Pharmacol Ther 96:247–255

Article  CAS  PubMed  Google Scholar 

Bovbjerg D, Kim YT, Siskind GW, Weksler ME (1987) Conditioned suppression of plaque-forming cell responses with cyclophosphamide. The role of taste aversion. Ann N Y Acad Sci 496:588–594

Article  CAS  PubMed  Google Scholar 

Brinkmann V (2009) FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system. Br J Pharmacol 158:1173–1182

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, Francis G, Aradhye S, Burtin P (2010) Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov 9:883–897

Article  CAS  PubMed  Google Scholar 

Chun J, Giovannoni G, Hunter SF (2021) Sphingosine 1-phosphate receptor modulator therapy for multiple sclerosis: Differential downstream receptor signalling and clinical Profile effects. Drugs 81:207–231

Article  CAS  PubMed  Google Scholar 

Cipriani R, Chara JC, Rodríguez-Antigüedad A, Matute C (2017) Effects of FTY720 on brain neurogenic niches in vitro and after kainic acid-induced injury. J Neuroinflammation 14:147

Article  PubMed  PubMed Central  Google Scholar 

Cuello AC, Carson S (1983) Microdissection of fresh rat brain tissue slices. Brain Microdissection Techniques. Wiley, pp 37–125

Dumont FJ, Su Q (1996) Mechanism of action of the immunosuppressant rapamycin. Life Sci 58:373–395

Article  CAS  PubMed  Google Scholar 

Eikelboom R, Stewart J (1982) Conditioning of Drug-Induced physiological responses. Psychol Rev 89:507–528

Article  CAS  PubMed  Google Scholar 

Exton MS, Schult M, Donath S, Strubel T, Bode U, del Rey A, Westermann J, Schedlowski M (1999) Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation. Am J Physiol 276:R1710–1717

CAS  PubMed  Google Scholar 

Exton MS, Gierse C, Meier B, Mosen M, Xie Y, Frede S, Goebel MU, Limmroth V, Schedlowski M (2002) Behaviorally conditioned immunosuppression in the rat is regulated via noradrenaline and beta-adrenoceptors. J Neuroimmunol 131:21–30

Article  CAS  PubMed  Google Scholar 

Gajofatto A, Turatti M, Monaco S, Benedetti MD (2015) Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis. Drug Healthc Patient Saf 7:157–167

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goebel MU, Trebst AE, Steiner J, Xie YF, Exton MS, Frede S, Canbay AE, Michel MC, Heemann U, Schedlowski M (2002) Behavioral conditioning of immunosuppression is possible in humans. FASEB J 16:1869–1873

Article  CAS  PubMed  Google Scholar 

Gorczynski RM, Kennedy M (1987) Behavioral trait associated with conditioned immunity. Brain Behav Immun 1:72–80

Article  CAS  PubMed  Google Scholar 

Gottschalk S, Cummins CL, Leibfritz D, Christians U, Benet LZ, Serkova NJ (2011) Age and sex differences in the effects of the immunosuppressants cyclosporine, sirolimus and everolimus on rat brain metabolism. Neurotoxicology 32:50–57

Article  CAS  PubMed  Google Scholar 

Grochowicz PM, Schedlowski M, Husband AJ, King MG, Hibberd AD, Bowen KM (1991) Behavioral conditioning prolongs heart allograft survival in rats. Brain Behav Immun 5:349–356

Article  CAS  PubMed  Google Scholar 

Hadamitzky M, Schedlowski M (2022) Harnessing associative learning paradigms to optimize drug treatment. Trends Pharmacol Sci 43:464–472

Article  CAS  PubMed  Google Scholar 

Hadamitzky M, Herring A, Keyvani K, Doenlen R, Krugel U, Bosche K, Orlowski K, Engler H, Schedlowski M (2014) Acute systemic rapamycin induces neurobehavioral alterations in rats. Behav Brain Res 273:16–22

Article  CAS  PubMed  Google Scholar 

Hadamitzky M, Bosche K, Wirth T, Buck B, Beetz O, Christians U, Schniedewind B, Luckemann L, Gunturkun O, Engler H, Schedlowski M (2016) Memory-updating abrogates extinction of learned immunosuppression. Brain Behav Immun 52:40–48

Article  CAS  PubMed  Google Scholar 

Hadamitzky M, Herring A, Kirchhof J, Bendix I, Haight MJ, Keyvani K, Lückemann L, Unteroberdörster M, Schedlowski M (2018) Repeated systemic treatment with Rapamycin affects behavior and amygdala protein expression in rats. Int J Neuropsychopharmacol 21:592–602

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hadamitzky M, Lückemann L, Pacheco-López G, Schedlowski M (2020) Pavlovian conditioning of immunological and neuroendocrine functions. Physiol Rev 100:357–405

Article  CAS  PubMed  Google Scholar 

Herz J, Köster C, Crasmöller M, Abberger H, Hansen W, Felderhoff-Müser U, Bendix I (2018) Peripheral T cell depletion by FTY720 exacerbates hypoxic-ischemic brain Injury in neonatal mice. Front Immunol 9:1696

Article  PubMed  PubMed Central  Google Scholar 

Hetze S, Barthel L, Lückemann L, Günther HS, Wülfing C, Salem Y, Jakobs M, Hörbelt-Grünheidt T, Petschulat J, Bendix I, Weber-Stadlbauer U, Sure U, Schedlowski M, Hadamitzky M (2022) Taste-immune associative learning amplifies immunopharmacological effects and attenuates disease progression in a rat glioblastoma model. Brain Behav Immun 106:270–279

Article  CAS  PubMed  Google Scholar 

Hörbelt T, Martínez-Gómez EM, Hadamitzky M, Schedlowski M, Lückemann L (2019) Behaviorally conditioned immunosuppression with cyclosporine a forms long lasting memory trace. Behav Brain Res 376:112208

Article  PubMed  Google Scholar 

Ingwersen J, Aktas O, Kuery P, Kieseier B, Boyko A, Hartung HP (2012) Fingolimod in multiple sclerosis: mechanisms of action and clinical efficacy. Clin Immunol 142:15–24

Article  CAS  PubMed  Google Scholar 

Kirchhof J, Petrakova L, Brinkhoff A, Benson S, Schmidt J, Unteroberdörster M, Wilde B, Kaptchuk TJ, Witzke O, Schedlowski M (2018) Learned immunosuppressive placebo responses in renal transplant patients. Proc Natl Acad Sci U S A 115:4223–4227

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klosterhalfen W, Klosterhalfen S (1983) Pavlovian conditioning of immunosuppression modifies adjuvant arthritis in rats. Behav Neurosci 97:663–666

Article  CAS  PubMed  Google Scholar 

Kovarik JM, Schmouder R, Barilla D, Wang Y, Kraus G (2004) Single-dose FTY720 pharmacokinetics, food effect, and pharmacological responses in healthy subjects. Br J Clin Pharmacol 57:586–591

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krivinko JM, Erickson SL, MacDonald ML, Garver ME, Sweet RA (2022) Fingolimod mitigates synaptic deficits and psychosis-like behavior in APP/PSEN1 mice. Alzheimers Dement (N Y), 8, e12324

Leisengang S, Schedlowski M, Hadamitzky M, Lückemann L (2022) Taste-associative learning in rats: conditioned immunosuppression with cyclosporine A to Study the Neuro-Immune Network. Curr Protoc 2:e573